IP Library › Granted Patent US 10,376,620
Granted Patent B2
US 10,376,620 · App. 14/677,319 · Granted Aug 13, 2019

Systems and methods for leukoreducing a red blood cell-containing fluid and concentrated red blood cells

Inventors: Daniel R. Lynn (Spring Grove, IL); Daryl R. Calhoun (Gurnee, IL)
Assignee: Fenwal, Inc.
A61M1/0218A61M1/0272A61M1/265A61M1/3633C12N5/0641A61M2202/0429
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,376,620
App. No.
14/677,319
Granted
Aug 13, 2019
Kind
B2
Abstract

Systems and methods are provided for separating a red blood cell-containing fluid into separated red blood cells and another fluid constituent. A suitable system includes a disposable fluid flow circuit and a durable, reusable separation system, with the circuit being mounted onto or otherwise associated with the separation system. The circuit includes a membrane separator for separating the fluid into its constituent parts, as well as a leukoreduction filter. The leukoreduction filter may be used before or after the red blood cell-containing fluid has been passed into the membrane separator. The red blood cell-containing fluid (if the leukoreduction filter is positioned upstream of the membrane separator) or the separated red blood cells (if the leukoreduction filter is positioned downstream of the membrane separator) may also be passed through a microaggregate filter prior to passing through the leukoreduction filter.

Claims (39)

1. A fluid flow circuit for separating whole blood into separated red blood cells and another fluid constituent, the fluid flow circuit comprising:

a membrane separator including an inlet port and a red blood cell outlet port;

an inlet flow path in fluid communication with the inlet port;

an outlet flow path associated with the red blood cell outlet port;

a leukoreduction filter associated with the outlet flow path; and

a microaggregate filter positioned between the red blood cell outlet port and the leukoreduction filter, wherein the outlet flow path includes tubing connecting the leukoreduction filter to the microaggregate filter.

2. The fluid flow circuit of claim 1 , wherein the outlet flow path is configured to be associated with an outlet pump positioned downstream of the membrane separator to pump separated red blood cells through the outlet flow path.

3. The fluid flow circuit of claim 2 , wherein the leukoreduction filter includes flexible walls and is configured to collapse after separated red blood cells are pumped therethrough upon continued operation of the outlet pump.

4. The fluid flow circuit of claim 3 , further comprising a flow path branch associated with the outlet flow path and configured to be associated with a pressure sensor to determine whether the leukoreduction filter has collapsed.

5. The fluid flow circuit of claim 1 , wherein the outlet flow path is configured to be associated with an outlet pump positioned downstream of the membrane separator and upstream of the leukoreduction filter to pump separated red blood cells through the outlet flow path.

6. The fluid flow circuit of claim 1 , wherein the outlet flow path is configured to be associated with an outlet pump positioned downstream of the membrane separator and downstream of the leukoreduction filter to pump separated red blood cells through the outlet flow path.

7. The fluid flow circuit of claim 1 , further comprising

a storage container associated with the outlet flow path and configured to receive separated red blood cells flowed through the leukoreduction filter and the microaggregate filter, and

an additive container associated with the outlet flow path, wherein the fluid flow circuit is configured to be associated with an additive pump to pump a storage solution or an additive through the microaggregate filter and the leukoreduction filter to mix with the separated red blood cells in the storage container.

8. The fluid flow circuit of claim 1 , wherein the microaggregate filter comprises a filter sock with a length of approximately four inches and a pore size of approximately 80 microns.

9. A method of separating whole blood into separated red blood cells and another fluid constituent comprising:

providing whole blood;

flowing the whole blood through an inlet flow path and into a membrane separator;

separating the whole blood into separated red blood cells and another fluid constituent; and

flowing the separated red blood cells out of the membrane separator via an outlet flow path; into, through, and out of a microaggregate filter; and into an inlet of a leukoreduction filter, through, and out of the leukoreduction filter.

10. The method of claim 9 , wherein said flowing the separated red blood cells out of the membrane separator includes pumping the separated red blood cells through the outlet flow path using an outlet pump positioned downstream of the membrane separator.

11. The method of claim 10 , wherein

the leukoreduction filter includes flexible walls, and

said flowing the separated red blood cells out of the membrane separator includes pumping the separated red blood cells through the leukoreduction filter until the leukoreduction filter collapses.

12. The method of claim 11 , further comprising sensing pressure in the outlet flow path to determine whether the leukoreduction filter has collapsed.

13. The method of claim 10 , wherein said outlet pump is positioned upstream of the leukoreduction filter.

14. The method of claim 10 , wherein said outlet pump is positioned downstream of the leukoreduction filter.

15. The method of claim 9 , wherein said flowing the whole blood through an inlet flow path and into a membrane separator includes pumping the whole blood into the inlet flow path from a flexible container and continuing to operate the inlet pump after the flexible container has been emptied of the red blood cell-containing fluid.

16. The method of claim 9 , further comprising storing the whole blood in a fluid source container for up to three days prior to said flowing the whole blood through an inlet flow path and into a membrane separator.

17. The method of claim 9 , wherein said flowing the separated red blood cells out of the membrane separator includes flowing the separated red blood cells from the leukoreduction filter into a storage container, and further comprising pumping a storage solution or an additive through the microaggregate filter and the leukoreduction filter to mix with the separated red blood cells in the storage container.

18. The method of claim 9 , wherein the microaggregate filter comprises a filter sock.

19. The method of claim 9 , wherein the microaggregate filter comprises a filter sock with a length of approximately four inches and a pore size of approximately 80 microns.

20. The method of claim 9 , wherein said flowing the flowing the separated red blood cells out of the membrane separator via the outlet flow path; into, through, and out of the microaggregate filter; and into the inlet of the leukoreduction filter, through, and out of the leukoreduction filter includes flowing the separated red blood cells from the microaggregate filter, through a tubing, and into the inlet of the leukoreduction filter.

21. A method of separating a red blood cell-containing fluid into separated red blood cells and another fluid constituent comprising:

providing a red blood cell-containing fluid;

flowing the red blood cell-containing fluid through an inlet flow path and into a membrane separator;

separating the red blood cell-containing fluid into separated red blood cells having a hematocrit of approximately 80-85% and another fluid constituent; and

flowing the separated red blood cells out of the membrane separator via an outlet flow path; into, through, and out of a microaggregate filter; and into an inlet of a leukoreduction filter, through, and out of the leukoreduction filter.

22. The method of claim 21 , wherein said flowing the flowing the separated red blood cells out of the membrane separator via the outlet flow path; into, through, and out of the microaggregate filter; and into the inlet of the leukoreduction filter, through, and out of the leukoreduction filter includes flowing the separated red blood cells from the microaggregate filter, through a tubing, and into the inlet of the leukoreduction filter.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 2, 2015
From: LYNN, DANIEL R.; CALHOUN, DARYL R.
To: FENWAL, INC.
Reel/Frame 035322/0637 →
Continuity (1)
Related Publication 20160289638A1 · Oct 6, 2016
Cited By (1)
US 12,390,573